Humana Inc. (NYSE:HUM) Stake Maintained by Mascoma Wealth Management LLC
Mascoma Wealth Management LLC maintained its stake in Humana Inc. (NYSE:HUM) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 430 shares of the insurance provider’s stock at the end of the second quarter. Mascoma Wealth Management LLC’s holdings in Humana were worth $103,000 at the end of the most recent reporting period.
Other hedge funds also recently added to or reduced their stakes in the company. Guardian Life Insurance Co. of America boosted its stake in Humana by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 575 shares of the insurance provider’s stock worth $119,000 after buying an additional 4 shares during the period. Independent Portfolio Consultants Inc. boosted its stake in Humana by 22.1% in the second quarter. Independent Portfolio Consultants Inc. now owns 519 shares of the insurance provider’s stock worth $125,000 after buying an additional 94 shares during the period. Point72 Asia Hong Kong Ltd bought a new stake in Humana during the first quarter worth approximately $128,000. MUFG Americas Holdings Corp bought a new stake in Humana during the first quarter worth approximately $221,000. Finally, Mirae Asset Global Investments Co. Ltd. bought a new stake in Humana during the first quarter worth approximately $223,000. Institutional investors own 99.66% of the company’s stock.
Shares of Humana Inc. (HUM) opened at 249.62 on Tuesday. The stock has a market cap of $36.07 billion, a price-to-earnings ratio of 20.53 and a beta of 0.91. Humana Inc. has a 12-month low of $163.50 and a 12-month high of $251.79. The stock’s 50 day moving average is $236.19 and its 200-day moving average is $220.68.
Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 earnings per share for the quarter, beating analysts’ consensus estimates of $3.08 by $0.41. Humana had a return on equity of 15.85% and a net margin of 3.37%. The business had revenue of $13.53 billion during the quarter, compared to analysts’ expectations of $13.61 billion. During the same quarter last year, the business posted $2.30 earnings per share. Equities analysts anticipate that Humana Inc. will post $11.42 EPS for the current fiscal year.
Several analysts have commented on the stock. Cowen and Company restated an “outperform” rating and set a $230.00 price objective on shares of Humana in a research note on Tuesday, April 25th. Leerink Swann lifted their price objective on shares of Humana from $250.00 to $265.00 and gave the company an “outperform” rating in a research note on Tuesday, May 30th. Zacks Investment Research upgraded shares of Humana from a “hold” rating to a “buy” rating and set a $257.00 price objective for the company in a research note on Thursday, May 25th. BidaskClub cut shares of Humana from a “buy” rating to a “hold” rating in a research note on Tuesday, June 13th. Finally, UBS AG restated a “neutral” rating and set a $237.00 price objective (up from $205.00) on shares of Humana in a research note on Wednesday, June 28th. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and twelve have issued a buy rating to the company’s stock. Humana presently has a consensus rating of “Hold” and a consensus price target of $243.00.
In related news, VP Heidi S. Margulis sold 1,500 shares of Humana stock in a transaction dated Friday, May 26th. The stock was sold at an average price of $231.96, for a total transaction of $347,940.00. Following the completion of the sale, the vice president now owns 8,150 shares in the company, valued at approximately $1,890,474. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Brian P. Leclaire sold 4,971 shares of Humana stock in a transaction dated Wednesday, June 28th. The stock was sold at an average price of $240.00, for a total value of $1,193,040.00. Following the sale, the senior vice president now owns 14,258 shares of the company’s stock, valued at approximately $3,421,920. The disclosure for this sale can be found here. Company insiders own 0.80% of the company’s stock.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Stock Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related stocks with our FREE daily email newsletter.